Literature DB >> 6888862

The differential diagnosis of malignant melanoma of the iris. A clinical study of 200 patients.

J A Shields, G E Sanborn, J J Augsburger.   

Abstract

The records of 200 consecutive patients referred to the Ocular Oncology Service of Wills Eye Hospital because of an iris lesion suspected of being an iris melanoma were reviewed. On clinical evaluation, 24% of the lesions met the criteria for the diagnosis of iris melanoma and 76% were diagnosed as simulating lesions (pseudomelanomas). The most common pseudomelanomas included primary iris cyst (38%), iris nevus (31%), essential iris atrophy (5.7%), iris foreign body (4.5%), peripheral anterior synechia (2.5%), and iris metastasis (2.5%). Less frequently encountered pseudomelanomas included aphakic iris cysts, leiomyoma, melanocytoma, reactive lymphoid hyperplasia, adenoma of iris pigment epithelium, iridoschisis, and other miscellaneous entities. The clinical features that are helpful in differentiating the more common iris pseudomelanomas from true melanomas are discussed. Correct clinical identification of these simulating lesions may prevent unnecessary surgery or other treatment.

Entities:  

Mesh:

Year:  1983        PMID: 6888862     DOI: 10.1016/s0161-6420(83)34500-0

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  30 in total

Review 1.  Don't it make my blue eyes brown: heterochromia and other abnormalities of the iris.

Authors:  I G Rennie
Journal:  Eye (Lond)       Date:  2011-10-07       Impact factor: 3.775

2.  Diagnostic ultrasound: an aid in the differentiation of anterior segment lesions of the eye.

Authors:  A M Verbeek; P Mitropoulos
Journal:  Int Ophthalmol       Date:  1991-05       Impact factor: 2.031

3.  Retained intraocular foreign body masquerading as malignant melanoma of the iris.

Authors:  W Maat; G S Missotten; G P M Luyten; R J W de Keizer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-12-18       Impact factor: 3.117

4.  Plaque radiotherapy treatment with ruthenium-106 for iris malignant melanoma.

Authors:  M Tsimpida; J Hungerford; A Arora; V Cohen
Journal:  Eye (Lond)       Date:  2011-09-23       Impact factor: 3.775

5.  Iris pigmentation and pigmented lesions: an ultrastructural study.

Authors:  R C Eagle
Journal:  Trans Am Ophthalmol Soc       Date:  1988

6.  Irradiating iris tumours.

Authors:  I Rennie
Journal:  Br J Ophthalmol       Date:  1995-04       Impact factor: 4.638

7.  Conventional diagnostic ultrasound of iris lesions.

Authors:  A M Verbeek
Journal:  Doc Ophthalmol       Date:  1995       Impact factor: 2.379

8.  Factors associated with elevated intraocular pressure in eyes with iris melanoma.

Authors:  C L Shields; M A Materin; J A Shields; E Gershenbaum; A D Singh; A Smith
Journal:  Br J Ophthalmol       Date:  2001-06       Impact factor: 4.638

9.  Proton beam therapy for presumed and confirmed iris melanomas: a review of 36 cases.

Authors:  Ahmed Rahmi; Hamid Mammar; Juliette Thariat; Gaelle Angellier; Joel Herault; Pierre Chauvel; Laurent Kodjikian; Philippe Denis; Jean Daniel Grange
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-07-20       Impact factor: 3.117

10.  Iris nevi and melanomas: a clinical follow-up study.

Authors:  F van Klink; R J de Keizer; M J Jager; H M Kakebeeke-Kemme
Journal:  Doc Ophthalmol       Date:  1992       Impact factor: 2.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.